XML 101 R69.htm IDEA: XBRL DOCUMENT v3.21.2
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Numerator:        
Net income attributable to Biogen Inc. $ 448.5 $ 1,542.1 $ 858.7 $ 2,941.2
Weighted-average shares used in calculating:        
Weighted average number of common shares outstanding 149.7 160.6 150.8 166.7
Effect of dilutive securities:        
Dilutive potential common shares 0.4 0.3 0.4 0.3
Shares used in calculating diluted earnings per share 150.1 160.9 151.2 167.0
Time-vested restricted stock units        
Effect of dilutive securities:        
Stock units 0.2 0.1 0.2 0.1
Market stock units        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.1 0.1
Performance stock units settled in stock        
Effect of dilutive securities:        
Stock units 0.1 0.1 0.1 0.1